Company news

Krtl Holding Group, Inc (OTC:KRTL) news

Krtl Holding Group, Inc news releases on 6ix. Latest, Sep 28, 2026: KRTL Holding Group Announces Strategic Project Relationship with Fortune Nickel & Gold…

Krtl Holding Group, Inc (OTC:KRTL) news

Press releases & updates

KRTL Holding Group Announces Strategic Project Relationship with Fortune Nickel & Gold and Provides Acton Project Update

KRTL Holding Group Provides KRTL MedHealth Update on Platform Development, Physician Credentialing and Potential Standalone Positioning

KRTL Holding Group Provides Acton-Area Historic Mineral Validation Project Update

KRTL Holding Group Provides KRTL International Update on Federal, Cross-Border and Strategic Project Development

KRTL Holding Group Provides KRTL Biotech Update on Pharmaceutical, Botanical and Federal Development

KRTL Holding Group Provides Shareholder Update on Corporate Progress and Subsidiary Development

KRTL Biotech Expands Regulatory and Partner-Qualification Framework for South American API and Controlled-Substance Pharmaceutical Development

KRTL Biotech Appoints Federal Controlled-Substance Compliance Specialist Justin Abril as President-Designate

KRTL Holding Group Signs RAYEL Cooperation Agreement with Centro de Investigaciones Químicas S.R.L.

KRTL Completes PERIKO and RAYEL IP Acquisition, Advancing Coca-Derived Extract Platform Toward Commercialization

KRTL Holding Group Announces RAYEL and PERIKO Coca-Derived Extract Platform for Beverage and Pharmaceutical API Development

KRTL Holding Group Inc. Highlights Growth Initiatives at Camelot's Nutrition Corp.

KRTL Holding Group, Inc. Introduces Strategic Red Rover Mine Initiative in Acton, California

KRTL Holding Group, Inc. and Aura Nootropics Advance Thailand-Focused Methylene Blue Initiative

KRTL Holding Group, Inc. Advances Methylene Blue Initiative Through Strategic Partnership with Aura Nootropics

KRTL Holding Group, Inc. Announces Formation of KRTL MedHealth Corp., a Healthcare Operations and Provider Support Company

KRTL Holding Group, Inc. Welcomes Teresa Wheeler to Leadership Team

KRTL HOLDING GROUP INC. ANNOUNCES STRATEGIC PARTNERSHIP BETWEEN KRTL BIOTECH AND AMNI PHARMACEUTICALS TO ADVANCE INTEGRATED PHARMACEUTICAL PLATFORM

KRTL and AMNI Pharmaceuticals Launch Strategic Distribution Collaboration

KRTL Holding Group, Inc. Announces Exclusive Distribution and Commercialization Agreement With Star Pharmaceuticals

KRTL Holding Group, Inc. Reduces Legacy Share Count Following New Court Order Supporting Disclosure Baseline

KRTL Streamlines Operations and Key Relationships to Support Broker-Dealer 15c2-11 Review and Disclosure Readiness

KRTL Holding Group Inc. (OTC:KRTL) Announces Product Launch from Subsidiary Camelot’s Nutrition Corp.: Knightmare Reflective Shoelace Weights Now Available

KRTL Holding Group Inc. and Industria Químico Farmacéutica Sigma Corp. S.R.L. Announce Mutual Rescission of Merger Agreement

KRTL Holding Group Inc. (OTC:KRTL) Acquires Majority Stake in Camelot’s Nutrition Corp., Expanding Its Footprint in the U.S. Health and Nutrition Market

KRTL Holding Group Announces Court Order Approving Further Cancellation and Correction of Legacy Shares and Establishing Corporate Baseline

KRTL Biotech Highlights Ophthalmic Pharmaceutical Capabilities to Address Vision Care Needs in Emerging and Global Markets

KRTL HOLDING GROUP INC. REPORTS THIRD QUARTER 2025 RESULTS (UNAUDITED) AND FILES PCAOB-AUDITED 2024 AND 2023 FINANCIAL STATEMENTS

KRTL Holding Group Inc. Publishes Investor Presentation

KRTL Biotech Highlights Anti-Allergy and Respiratory Product Capabilities to Address Global Market Needs

KRTL Holding Group Highlights Bolivian Innovation CaviGuard, Manufactured by SIGMA, as Global Model in Non-Invasive Dental Care

Correction: KRTL Holding Group Congratulates SIGMA on National Recognition for Pharmaceutical Excellence in Bolivia

KRTL Holding Group Congratulates SIGMA on National Recognition for Pharmaceutical Excellence in Bolivia

KRTL Biotech Spotlights Anti-Infectives and Antibiotics Portfolio to Support Public Health and Global Treatment Access

KRTL Holding Group Provides Corporate Update: SIGMA Integration, Regulatory Progress, and PCAOB Audit Engagement

KRTL Biotech Showcases Gastrointestinal Health Portfolio to Address Global Demand for Accessible Digestive Care

KRTL Biotech to Expand Pain Management Reach into U.S. and Global Healthcare Markets

KRTL Biotech Advances Global Access to Women’s Health Pharmaceuticals Through Strategic Portfolio Expansion

Patricia Wilstermann: A Trailblazing Leader Transforming Bolivia’s Pharmaceutical Industry

KRTL Biotech Highlights Pediatric Product Line to Support Childhood Wellness and Global Public Health

KRTL Biotech Highlights ELIXIR as Flagship Hydration Product in Bolivia

KRTL Biotech Launches Nutraceuticals Initiative in Partnership with SIGMA and Bolivian Health Programs

KRTL Biotech Inc. Introduces Expanded Pharmaceutical Portfolio Following Strategic Acquisition

KRTL Holding Highlights SIGMA’s 50-Year Legacy of Innovation, Quality, and Community Leadership in Bolivia

KRTL Holding Group, Inc. Announces Merger with Industria Químico Farmacéutica Sigma Corp. S.R.L.

KRTL Holding Group, Inc. Reports Strong Year-Over-Year Growth for Second Quarter 2025

KRTL Biotech Inc. Strengthens Import Operations with Official Customs Broker Appointment, Paving the Way for Global API Expansion

KRTL Holding Group Inc. (OTC: KRTL) Bolsters Corporate Leverage with Trademark Recognition and Structural Integration

KRTL Biotech Inc. Advances API Supply Chain Strategy with $240,000 Initial Purchase Order

KRTL Holding Appoints Dave Orn and Rick Haxton to Accelerate Global Growth at KRTL Biotech Inc.